In May 2019 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the bodybuilder Naresh Kumar after his sample tested positive for the prohibited Clomifene, Ibutamoren and LGD-4033.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substances and stated that he had used supplements recommended by a friend while he was unaware they contained the prohibited substances.
The Panel finds that the test result showed the presence of prohibited substances in the Athlete’s sample and accordingly that he committed an anti-doping rule violation. The Panel concludes that the Athlete failed to establish that the violation was not intentional nor how the prohibited substances entered his system.
Therefore the Panel decides on 3 January 2020 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 22 May 2019.